What this study is
The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.
What's being tested
- Data Collection
Intervention · OTHER
Participant information collected from either source document or direct participant response.
- Follow Up
Intervention · BEHAVIORAL
Participants followed up at the return to clinic visits. If participant cannot come to clinic, either a questionnaire mailed requesting follow-up, or participant called. Participants followed for a length of 15 years at intervals of every 2-3 years.
Study details
- Sponsor
- M.D. Anderson Cancer Center
- Conditions
- Endocrine Disease
- Enrolling
- 15,000 people
- Starts
- 2011-10-05
- Est. completion
- 2027-10
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic.
- In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Texas MD Anderson Cancer Center
Houston, Texas, United States
Recruiting
Study team
Sponsor
M.D. Anderson Cancer Center
Study ID PA11-0695
Principal investigator
Nancy D. Perrier, MD
M.D. Anderson Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.